Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

QT Imaging Holdings Inc

QT Imaging Holdings Inc

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

QT Imaging Holdings, Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low frequency sound waves. Its medical imaging is critical to the detection, diagnosis, and treatment of disease. The Company offers two products: QT Breast Scanner and QTviewer. QT Breast Scanner is a fixed, mechanical scanner used to evaluate the breast without the use of either ionizing radiation or compression associated with mammography, or the injections required for breast MRI. The QT Breast Scanner provides sub-millimeter, high-definition, image resolution enabling identification of normal and abnormal breast structures and the accurate depiction of the precise shape and location of findings. The QT Breast Scanner creates 3D images of the patient’s breast viewable in the Quantitative Transmission Ultrasound Viewer (QTviewer), a software product designed for healthcare professionals to view the transmission and reflection images.

  • Revenue in USD (TTM)0.00
  • Net income in USD-4.02m
  • Incorporated2021
  • Employees--
  • Location
    QT Imaging Holdings Inc3 Hamilton Landing, Suite 160NOVATO 94949United StatesUSA
  • Phone+1 (415) 842-7250
  • Fax+1 (302) 655-5049
  • Websitehttps://gigcapital5.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.